Article
Rubiscolin-6, a delta opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating sigma1 and dopamine D1 receptors.
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji, Kyoto 611-0011, Japan.
Peptides (impact factor:
2.43).
11/2007;
28(10):1998-2003.
DOI:10.1016/j.peptides.2007.07.024
pp.1998-2003
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Yes, I am ready now: differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats.
[show abstract] [hide abstract]
ABSTRACT: Sexual activity and partner intimacy results in several positive consequences in the context of stress-coping, both in males and females, such as reduced state anxiety in male rats after successful mating. However, in female rats, mating is a rewarding experience only when the estrous female is able to control sexual interactions, i.e., under paced-mating conditions. Here, we demonstrate that sex-steroid priming required for female mating is anxiolytic; subsequent sexual activity under paced mating conditions did not disrupt this anxiolytic priming effect, whereas mating under unpaced conditions increased anxiety-related behavior. In primed females, the release of the neuropeptide oxytocin (OT) within the hypothalamic paraventricular nucleus was found to be elevated and to further increase during paced, but not unpaced mating. Central administration of an OT receptor antagonist partly prevented priming/mating-induced anxiolysis indicating the involvement of brain OT in the anxiolysis triggered by priming and/or sexual activity.These findings reveal that the positive consequences of mating in females are dependent on her ability to control sexual interactions, and that brain OT release is at least in part the underlying neurobiological correlate.PLoS ONE 01/2011; 6(8):e23599. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
analgesic effect
anxiolytic activity
anxiolytic effect
anxiolytic effects
delta opioid peptide
delta opioid receptor
delta opioid receptor antagonist
dopamine D(1)
dopamine D(2)
elevated plus-maze test
large subunit
memory consolidation
oral
orally
raclopride
Rubiscolin-6